Analysis of Impact of KeryFlex on Quality of Life for Retronychia or Lichen Planus Adult Patients
Lichen Planus of Nail
About this trial
This is an interventional supportive care trial for Lichen Planus of Nail focused on measuring Retronychia, KeryFlex
Eligibility Criteria
Inclusion criteria: Diagnosis of retronychia or nail lichen planus Able to understand and voluntarily sign an informed consent form 18-95 years old at time of consent Able to adhere to the study visit schedule and other protocol requirements Exclusion criteria: Unable to provide written informed consent for any reason Diagnosis of peripheral vascular disease, arterial insufficiency, peripheral neuropathy, suspicious pigmented lesions on the nail or in-grown nails Sensitive or allergic to any KeryFlex ingredients Unable to abstain from using nail polishes, nail gels, or any other nail products 2 days prior to KeryFlex procedure and during the study period Pregnant, planning pregnancy, or nursing
Sites / Locations
- Weill Cornell Dermatology
Arms of the Study
Arm 1
Experimental
KeryFlex
Patients 18 years and older presenting with retronychia and/or lichens planus of the toenails and/or fingernails to the Weill Cornell Medicine, Department of Dermatology, specialized nail clinic.